Coastlands Capital LP
Transaction: 07/16/2026
BUY
Change
+1,233
Price
$2.75
Filing
07/16/2026
Type
BUY
Adial Pharmaceuticals, Inc.
ADIL • Biotechnology
$7.12
▲ +0.46 (+6.91%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$32.91M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 4.42Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 16, 2026, 12:22 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$7.12
Change6.91%
Shares Out4.62M
Market Cap$32.91M
Enterprise Value$4.19M
52W Range1.31 - 10.75
Beta1.43
P/E-0.57
P/B-0.86
P/FCF-2.96
EV/EBITDA-0.07
EV/FCF-0.38
Price$7.12
Change6.91%
Shares Out4.62M
Market Cap$32.91M
Enterprise Value$4.19M
52W Range1.31 - 10.75
Beta1.43
P/E-0.57
P/B-0.86
P/FCF-2.96
EV/EBITDA-0.07
EV/FCF-0.38
Earnings Yield-175.65%
FCF Yield-33.83%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio4.42
Quick Ratio4.42
Target$8.50
Target Upside19.38%
Target Median$8.50
Target Range6.00 - 11.00
Volume48.21K
Avg Volume345.34K
EPS Surprise1.25
Investment DNA
How strong this company looks for long-term investors
47
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 4.42Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 3 analyst votes · 2026-09-05
100/100
Bullish
Bullish
3
Hold
0
Bearish
0
Price Target
2026-08-16
Low
$6.00
Mean
$8.50
Median
$8.50
High
$11.00
Insider Transactions
Recent executive and insider activity
Coastlands Capital LP
Transaction: 07/14/2026
BUY
Change
+2,000
Price
$2.65
Filing
07/16/2026
Type
BUY
Coastlands Capital LP
Transaction: 07/10/2026
BUY
Change
+1,700
Price
$2.70
Filing
07/13/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Coastlands Capital LP | BUY | +1,233 | $2.75 | 07/16/2026 | 07/16/2026 |
| Coastlands Capital LP | BUY | +2,000 | $2.65 | 07/14/2026 | 07/16/2026 |
| Coastlands Capital LP | BUY | +1,700 | $2.70 | 07/10/2026 | 07/13/2026 |
| Coastlands Capital LP | BUY | +10,053 | $2.79 | 07/09/2026 | 07/13/2026 |
| Coastlands Capital LP | BUY | +25,000 | $2.60 | 06/29/2026 | 07/01/2026 |
| Coastlands Capital LP | OTHER | +3,637,818 | $0.00 | 06/24/2026 | 06/29/2026 |
| Coastlands Capital LP | OTHER | 0 | Not reported | 06/24/2026 | 06/29/2026 |
| Young Wendy B. | BUY | +36,378 | $0.00 | 06/12/2026 | 06/16/2026 |
| Davidson Matt | BUY | +232,417 | $2.89 | 06/12/2026 | 06/16/2026 |
| Davidson Matt | BUY | +232,417 | Not reported | 06/12/2026 | 06/16/2026 |
| Young Wendy B. | OTHER | 0 | Not reported | 06/11/2026 | 06/16/2026 |
| Davidson Matt | OTHER | 0 | Not reported | 06/11/2026 | 06/16/2026 |
| Davidson Matt | BUY | — | Not reported | 06/11/2026 | 06/16/2026 |
| Davidson Matt | BUY | +3,427 | Not reported | 06/11/2026 | 06/16/2026 |
| Claiborne Cary J | BUY | +37,985 | Not reported | 04/07/2026 | 04/09/2026 |
| Gilliland Robertson H. | BUY | +9,185 | Not reported | 04/07/2026 | 04/09/2026 |
| Shah Vinay | BUY | +17,325 | Not reported | 04/07/2026 | 04/09/2026 |
| Schuyler Kevin | BUY | +9,185 | Not reported | 04/07/2026 | 04/09/2026 |
| Anderson J. Kermit | BUY | +9,185 | $1.64 | 04/07/2026 | 04/09/2026 |
| Goodman Tony | BUY | +26,510 | Not reported | 04/07/2026 | 04/09/2026 |